Report for Tschanz JT

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care - Behrens_2018_Int.Psychogeriatr__1
Author(s) : Behrens S , Rattinger GB , Schwartz S , Matyi J , Sanders C , DeBerard MS , Lyketsos CG , Tschanz JT
Ref : Int Psychogeriatr , :1 , 2018
Abstract : Behrens_2018_Int.Psychogeriatr__1
ESTHER : Behrens_2018_Int.Psychogeriatr__1
PubMedSearch : Behrens_2018_Int.Psychogeriatr__1
PubMedID: 29559029

Title : Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression - Mielke_2012_Alzheimers.Dement_8_180
Author(s) : Mielke MM , Leoutsakos JM , Corcoran CD , Green RC , Norton MC , Welsh-Bohmer KA , Tschanz JT , Lyketsos CG
Ref : Alzheimers Dement , 8 :180 , 2012
Abstract : Mielke_2012_Alzheimers.Dement_8_180
ESTHER : Mielke_2012_Alzheimers.Dement_8_180
PubMedSearch : Mielke_2012_Alzheimers.Dement_8_180
PubMedID: 22301194